Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: July 23, 2026 at 1:05 AM UTC
| NCT Number | NCT06209606 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | EARLY_PHASE1 |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Oncotherapeutics |
| Last Updated on CT.gov | December 17, 2024 (Dec 17, 2024) |
As of July 23, 2026: Clinical trial NCT06209606 is currently recruiting participants. This early_phase1 study for multiple myeloma is actively seeking new participants at 1 location across the United States. The study is sponsored by Oncotherapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06209606 is actively recruiting participants as of July 23, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06209606 was last updated Dec 17, 2024 (December 17, 2024). HelloStudys verifies this status automatically.